Literature DB >> 19189688

Characteristics of primary hyperparathyroidism in adolescents.

S K Bhadada1, A Bhansali, P Dutta, A Behera, G V Chanukya, B R Mittal.   

Abstract

AIM: To analyze adolescent primary hyperparathyroidism (PHPT) in India.
DESIGN: A retrospective analysis of consecutive medical records of patients with PHPT < or =20 years old who underwent parathyroid surgery at a tertiary care center in north India from 1993 to 2006.
METHODS: Fourteen adolescents underwent clinical, biochemical, hormonal, radiological and scintigraphic evaluation for confirmation of PHPT followed by parathyroidectomy.
RESULTS: Mean (+/- SD) age of these patients was 15 +/- 3.9 years (8 female). All were symptomatic at presentation except one who had multiglandular involvement as a part of multiple endocrine neoplasia (MEN)-I screening. The common presenting manifestations included bone disease, recurrent nephrolithiasis and pancreatitis. Hypercalcemia was observed in eight of these patients. The mean (+/- SD) serum intact parathyroid hormone was 781 +/- 586 pg/ml. Ultrasonography localized an abnormal parathyroid gland in 12 (92%) of 14 patients, while 99mTc sestamibi scan (performed in 7) localized abnormal parathyroid glands in all (100%). All patients underwent bilateral neck exploration except one with MEN-I, who refused surgery. Twelve patients had single parathyroid adenoma and one had four-gland hyperplasia. Mean follow up was 44.1 months and none showed recurrence.
CONCLUSIONS: Children and adolescents with pathological fractures with features of rickets, recurrent urolithiasis and pancreatitis should be screened for PHPT. Surgery is the treatment of choice.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19189688     DOI: 10.1515/jpem.2008.21.12.1147

Source DB:  PubMed          Journal:  J Pediatr Endocrinol Metab        ISSN: 0334-018X            Impact factor:   1.634


  8 in total

Review 1.  A meta-analysis comparing the biochemistry of primary hyperparathyroidism in youths to the biochemistry of primary hyperparathyroidism in adults.

Authors:  Jeffrey Roizen; Michael A Levine
Journal:  J Clin Endocrinol Metab       Date:  2014-12       Impact factor: 5.958

2.  Outcomes of minimally invasive parathyroidectomy in pediatric patients with primary hyperparathyroidism owing to parathyroid adenoma: A single institution experience.

Authors:  Edna E Mancilla; Michael A Levine; N Scott Adzick
Journal:  J Pediatr Surg       Date:  2016-02-04       Impact factor: 2.545

Review 3.  Primary hyperparathyroidism in children and adolescents.

Authors:  Jeffrey Roizen; Michael A Levine
Journal:  J Chin Med Assoc       Date:  2012-08-21       Impact factor: 2.743

4.  Systematic review of primary hyperparathyroidism in India: the past, present, and the future trends.

Authors:  P V Pradeep; B Jayashree; Anjali Mishra; S K Mishra
Journal:  Int J Endocrinol       Date:  2011-05-26       Impact factor: 3.257

5.  Changes in clinical & biochemical presentations of primary hyperparathyroidism in India over a period of 20 years.

Authors:  Viral N Shah; Sanjay Bhadada; Anil Bhansali; Arnanshu Behera; B R Mittal
Journal:  Indian J Med Res       Date:  2014-05       Impact factor: 2.375

6.  Atypical skeletal manifestations of rickets in a familial hypocalciuric hypercalcemia patient.

Authors:  Bo Wu; Ou Wang; Yan Jiang; Mei Li; Xiaoping Xing; Weibo Xia
Journal:  Bone Res       Date:  2017-06-27       Impact factor: 13.567

7.  "Primary Hyperparathyroidism (PHPT) in Children: Two Case Reports and Review of the Literature".

Authors:  Gerdi Tuli; Jessica Munarin; Daniele Tessaris; Raffaele Buganza; Patrizia Matarazzo; Luisa De Sanctis
Journal:  Case Rep Endocrinol       Date:  2021-04-13

8.  A Pediatric Parathyroid Carcinoma: An Unusual Clinical Presentation and Mini-review.

Authors:  Abbas Rahimi; Roghayeh Shahbazi; Pooneh Nikuei; Sanaz Soleimani; Azadeh Moradkhani; Ali Atashabparvar; Farnaz Khajehrahimi; Ghazal Zoghi; Masoumeh Kheirandish
Journal:  Int J Endocrinol Metab       Date:  2021-01-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.